Bray Review Course AND Bray Obesity Symposium Package 2024
PBRC along with its distinguished faculty has been a world leader in obesity science and treatment for more than 30 years due in large part to the leadership of its first chief scientist and executive, George A Bray MD, an early pioneer in obesity research.
For this annual symposium, in honor of George A Bray MD, preeminent obesity experts from PBRC and around the US will elucidate the latest advances in the pathophysiology of obesity as well as advances in multidisciplinary obesity treatment.
Course Details
Our on-demand course offers learners the ability to access the materials asynchronously, at their own convenience and pace, through our online platform.
This on-demand symposium has been designated by the American Board of Obesity Medicine (ABOM) as a Group One Primary Medicine Obesity CME partner.
The content will consist of:
- An intensive Board Review Course in preparation for ABOM certification exam and will cover all key topics included in the exam.
- A variety of additional topics including advances in obesity genetics, new science, pediatric obesity, lifestyle intervention, pharmacotherapy, metabolic surgery, and more.
At the conclusion of the Bray Course, health care providers will take home with them powerful new obesity treatment strategies that they can implement into practice immediately for the betterment of their patients struggling with obesity.
- Materials Expiration Date: Materials will be available for viewing for up to two years after the course expiration date. All course PDFs may be downloaded.
This learning experience is intended for
- Physicians in Adult Medicine
- Pediatricians
- Specialists in Obesity Medicine
- Metabolic Surgeons
- Behavior Health Professionals
- Dietitians
- Nurse Practitioners
- Physician Assistants
- Nurses
- Lifestyle Counselors
- All health care providers and scientists interested in understanding and treating obesity
Learning Objectives
- Demonstrate an understanding of the determinants of obesity, including the role of genetics and epigenetics.
- Identify and evaluate patients with the chronic disease of obesity.
- Develop evidence-based obesity management options, including pharmacologic approaches, lifestyle interventions and metabolic surgery as patient-centered approaches for weight loss and improved outcomes in obesity comorbidities.
- Apply current multiple individualized treatment modalities to effectively address obesity.
- Describe issues of health disparities in obesity treatment, and formulate interventions to promote health equity.
Organizing Committee
- Director – Philip Schauer, MD, FACS, FASMBS
- Co-Director – Vivian Fonseca, MD FRCP
- Co-Director – Jaime Almandoz, MD, MBA, FTOS
- Co-Director – Steve Heymsfield, MD
- Leanne Redman, MS, PhD
- Donna Ryan, MD
- John Kirwan, MSc, PhD, FACSM
- Laura Boyer NP
- Holly Edmonds PA
- Pamala Schmidt
+ Topics:
